Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan

Table 1 Biochemical parameters of control subjects and patients with alcoholic liver disease (mean ± SE)

	Control	ALD
n	22	27
Male/female	19/3	23/4
Age (yr)	41.2 ± 2.1	45.3 ± 2.1
Height (cm)	169.7 ± 1.2	165.3 ± 1.3a
Weight (kg)	66.1 ± 1.8	65.4 ± 2.3
BMI (kg/m2)	23.9 ± 0.6	23.9 ± 0.8
AST (U/L)	20.7 ± 0.9	63.6 ± 8.7a
ALT (U/L)	22.6 ± 1.7	39.1 ± 5.2a
AST/ALT	1.0 ± 0.06	2.86 ± 0.86a
γ-GT (U/L)	29.2 ± 3.5	271.1 ± 81.3a
TC (mg/dL)	185.6 ± 5.5	153.7 ± 13.2a
TG (mg/dL)	99.4 ± 13.2	193.6 ± 61.2
HDL-C (mg/dL)	50.5 ± 3.1	36.7 ± 2.6a
LDL-C (mg/dL)	125.5 ± 6.8	72 ± 8.2a
Albumin (gm/dL)	4.75 ± 0.06	3.33 ± 0.18a
Uric acid (mg/dL)	6.26 ± 0.29	6.81 ± 0.45
Total bilirubin	0.56 ± 0.04	5.53 ± 2.21a

^aP < 0.05 vs the control group (by Student’s t-test). ALD: Alcoholic liver disease; BMI: Body-mass index; AST: Aspartate aminotransferase; ALT: Alanine transaminase; γ-GT: γ-glutamyltransferase; TC: Total cholesterol; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol.